Related Experiment Video
Updated: Aug 21, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Acute interstitial nephritis associated with atazanavir, a new protease inhibitor
Ursula C Brewster1, Mark A Perazella
1Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520-8029, USA.
Abstract:
Atazanavir is a new human immunodeficiency virus 1 protease inhibitor that has a favorable side-effect profile and is available in once-daily dosing. We report the case of a young man with human immunodeficiency virus infection who developed acute renal failure after therapy with this drug. Renal biopsy showed acute interstitial nephritis. This is the first report of acute interstitial nephritis from atazanavir.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Antihypertensive Drugs: Direct Renin Inhibitors
Antiviral Nucleoside Inhibitors

